We analyticallyand clinically evaluated a new commercial method ("SPAC Er') for simultaneouslydetermining total andfree thyroxinin serum. We foundthe methodto be rapid, simple, and precise. Results significantly correlated with those by "symmetric" dialysis and also agreed with the clinical data for patients with extremely low or high concentrations of thyroxin-binding globulin. On contrast, in those patients the most commonly used thyroid indexes (free thyroxin index or thyroxin:thyroxin-binding globulin ratio) failed to correctly reflect the truefunctional status of the thyroid.
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care unit. Most of them had multiple medical problems. The various primary diagnoses included cardiovascular diseases (congestive heart failure, sometimes aggravated by arrhythmiss, 30 patients), obstructive pulmonary disease (28 patients), renal failure (11 patients), gastrointestinal hemorrhage (eight patients), acute infectious disease (sepsis, peritonitis, pericarditis, six patients), and hepatic cirrhosis (four patients).
The diagnostic usefulness of the test was also tested in 1000 serum samples selected without conscious bias from those submitted to our routine clinical laboratory. Patients were classified as euthyroid, hypothyroid, or hyperthyroid on the basis of clinical examinations and results of independent biochemical tests (mostly the thyroliberin test).
Methods
Principle of the present method. Values for Fr4 were determined by a commercial indirect radioassay (SPAC ET; Byk Gulden Italia, Cormano, Italy) based on the principles described by Ross and Benraad (8) , in which the if4 fraction is measured in serum, where fT4 fraction = FF4iTI'4 = FFI(FF4 + protein-bound T4).
After a serum sample is pipetted into a SPAC ET tube coated with a low-affinity monoclonal T4 antibody of an appropriate binding capacity, the if4 fraction of the sample in the tube corresponds, at equilibrium, to the fT, fraction of the original sample: if4 fraction = FF/fl4 in the original sample = F1'4f1'F4 in the sample in the tube.
Thus, after addition of a T4 'I tracer with high specific activity, the antibody-bound T4 ("bound") is proportional to Fr4, and the non-antibody-bound T4 ("unbound") corresponds to 'FF4:
where K is the equilibrium constant depending on the affinity and binding capacity of the antibody. K is obtained by measuring the ratio of bound to unbound in a reference serum of a known IT4 fraction. The fF4 fraction of this serum was measured by symmetric dialysis (9), an optimized type of equilibrium dialysis, as the reference method: if4 fraction(sample) = ["bound"P'unbound"(sample)
#{247}
"bound"/"unbound" (reference)] x IT4 fraction (reference) Fr4 concentration is then calculated by multiplying the fT4 fraction by the #{182}I'F4 value that is simultaneously obtained by a conventional radioimmunoassay, with use of tubes coated with monoclonal antibody:
Procedure. Pipet 50 pL of serum sample and 1 mL of tracer, in that order, into the coated tubes, mix, and incubate for 120 miii at 37#{176}C. Aspirate the liquid phase, wash the tubes with 3 mL of distilled water, and count their radioactivity. with different Fr4 concentrations (low, medium, and high), using phosphate buffer (0.1 molIL, pH 7. 
Results
Analytical evaluation. The intra-and inter-assay precision of the SPAC ET method is summarized in Table 1 . The reproducibility (CV) of the method ranged from 5.0 to 12.7% in samples with different concentrations of Fr4. The dilution test performed in three sera at different concentrations showed no significant variation of Ff4, also true for more extreme sample dilutions ( Table 2 ). The observed variations are similar to those of the precision tests.
A significant correlation was observed between the refer- ence method for Fr4 determination (symmetric dialysis) and SPAC Fr (Figure 1) . A similar agreement was also found between the SPAC ET method and the chromatographic method (Lepetit), both for 250 unselected subjects (Figure 2 ) and for some selected groups of patients with thyroid disease or alteration of TBG concentration (Table 3) 
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#{149} . (Figure 4) . The mean value for Fr4 in patients with non-thyroidal ifiness was found to be slightly higher (14.5 ± 3.13 pmoJJL) in comparison with the reference subjects (13.5 ± 3.3 pmollL) . However, all but two of the nonthyroidally ill patients were correctly classified as euthyroid by Fr4. For these two patients the Fr4 values exceeded the normal reference interval.
Finally, we found a significant percentage of disagreement between PT4 and Fr4 in routine determinations, 136 of 1000 subjects (Table  4) . Values for Fr4 accorded with the clinical status in all but four patients; IT4 misclassified 132.
Discussion
The concentration of total thyroid hormones in serum is well known to be affected by alterations in transport protein, especially TBG concentration (14,15) . In fact, an increased or decreased concentration or binding capacity of transport proteins may result in similar changes in PT4 and PT3. As a result there has been an increasing tendency to determine the free hormone concentrations, mainly Fr4, directly or indirectly (FF1 or T4:TBG indexes). A better clinical effectiveness of free thyroxin determination, in comparison with derived indexes, in indicating the thyrometabolic status was reported (15-18) . However, most of the currently available methods do not appear to be adequate as a routine diagnostic tool. The proposed reference methods (equilibrium dialysis and symmetric dialysis) are time-consuming and cumbersome (19,9) ; the direct methods yield anomalous results in many clinical situations (20) (21) (22) (23) (24) (25) .
We found this new indirect radioimmunoassay on solid phase for F!'4 determination (SPAC ED to be rapid, simple, and precise and suited as a routine laboratory test. In fact, it exhibited a satisfactory reproducibility, and results correlated significantly with those by the symmetric dialysis and the chromatographic method for F!'4. based on T4 analog tracers, protein content does not seem to influence the results of the SPAC ET method, as shown by the dilution test. In fact, as reported by Ekins (16), a dilution up to 100-fold should decrease the apparent Fr4 concentration by only 2-3%, and this is proven theoretically, by equilibrium dialysis of samples and by the present method.
From a clinical point of view, despite the significant correlation observed between results by this method and the calculated free thyroxin indexes (FF1 or T4:TBG) we found some discrepancies for sera with abnormally low or high TBG concentration.
In particular, the poor value of the thyroid hormone:TBG ratio reported by some authors (26, 27) was confirmed by our results in children with TBG deficiency and in pregnant women. In addition, the inability of FF1 to correctly determine the functional thyroid status in TBG-deficient patients is well known and was suggested to be related to insensitivity of the T3 uptake test at belownormal TBG levels (28, 29) . Furthermore, Fl'! fails to compensate for increased concentration of carrier proteins because of the nonlinear relationship between P3 uptake and TBG (11) .
In contrast, the combined determination of IF4 and F!'4 obtained with the SPAC ET method provided correct information about thyroid function and also about the status of transport proteins in patients with extremely low or high TBG concentrations (pregnant women and children with inherited TBG deficiency). Similar, albeit less evident, alterations of carrier proteins could account for the disagreements between I'F4 and Fr4 observed in our routine practice: IT4, especially in hyperthyroid patients, often fails to detect the altered thyrometabolic status because of decreased PEG (30).
The clinical reliability of the present method for patients with non-thyroidal illness was shown in our tests on sick euthyroid patients with liver-disease and other critical illnesses. Similar results were also reported by K#{246}hn (31).
Finally, the method is not interfered with by some hormones (estrogens and contraceptive steroids) or drugs (heparin, phenytoin, acetylsalicylic acid) as reported by others (31, 32).
In conclusion: the simultaneous determination of rF4 and F!'4 by the SPAC ET method seems to be an updated and time-saving approach to thyroid-function testing.
